Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
01/03/2008 | WO2004081226A3 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use |
01/03/2008 | US20080005809 sequences from maize, soybean and Arabidopsis thaliana associated with transcription factors; genome mapping, gene identification and analysis, plant breeding, preparation of constructs for use in plant gene expression and transgenic plants |
01/03/2008 | US20080004435 Corticotropin releasing factor 2 receptor agonists |
01/03/2008 | US20080004434 prokaryotic host cells comprising a library of at least 103 different RNA molecules each having a dicistronic coding region; for screening a larger portion of the immunological repertoire for receptors having a preselected activity |
01/03/2008 | US20080004432 HEMCM42 antibodies |
01/03/2008 | US20080004231 Disease-Associated Protein |
01/03/2008 | US20080004229 Methods and Compositions Related to Skcg-1, a Tumor Suppressor |
01/03/2008 | US20080004211 Inhibitors of Amyloid Fibril Formation and Uses Thereof |
01/03/2008 | US20080003695 Enriched Pag-55 Fraction and Methods for Early Detection of Preganancy in Ungulate Animals |
01/03/2008 | US20080003693 Methods and materials for detecting frameshift mutations |
01/03/2008 | US20080003646 Stable, humanized, high affinity antibodies against carcinoembryonic antigen (CEA); complementary determining regions; vectors, host cells; pharmacokinetics |
01/03/2008 | US20080003644 Process for Obtaining Antibodies |
01/03/2008 | US20080003643 Methods of Synthesizing Heteromultimeric Polypeptides in Yeast Using a Haploid Mating Strategy |
01/03/2008 | US20080003623 Monitoring Agent for Seriousness of Hepatitis |
01/03/2008 | US20080003617 Methods for the identification and the isolation of epitope specific antibodies |
01/03/2008 | US20080003614 Mitochondrial anti-viral signaling protein; activates the NF- kappa B and IRF families of transcription factors to induce interferons in viral infected cells to clear viral infection |
01/03/2008 | US20080003608 Highly Specific Polyclonal Antibodies of Individual Core Histone and Uses Thereof |
01/03/2008 | US20080003263 Anti-Gluten Egg Yolk Antibodies for the Treatment of Celiac Disease |
01/03/2008 | US20080003230 Composition for modulating the expression of cell adhesion molecules |
01/03/2008 | US20080003229 the polypeptide induces an immune response directed both against the immunodominant region and against the protein of the host; vaccine |
01/03/2008 | US20080003228 Immunotherapy; combination with codeine phosphate, naproxen, diclofenac, indomethacin, or ibuprofen |
01/03/2008 | US20080003227 Acetyl CoA Carboxylase Splice Variant and Uses Thereof |
01/03/2008 | US20080003226 Method to Reduce Hepatoxicity of Fas-Mediated Apoptosis-Inducing Agents |
01/03/2008 | US20080003224 Compositions and methods for treating haematological proliferative disorders |
01/03/2008 | US20080003221 Compositions and methods for treating inflammatory lung disease |
01/03/2008 | US20080003218 Anti-IgE antibodies |
01/03/2008 | US20080003217 Ilk inhibitors for the treatment of renal disease |
01/03/2008 | US20080003216 Administering an interleukin-18 binding protein (IL-18BP) for inhibiting melanoma cell liver and lung tissue metastasis; IL-18 (IFN gamma-inducing factor) |
01/03/2008 | US20080003210 Non-human primate receptor tyrosine kinases |
01/03/2008 | US20080003178 PIF tetrapeptides |
01/03/2008 | US20080000405 S-adenosylmethionine Synthetase Expression Elements Identified from Arabidopsis thaliana |
01/03/2008 | CA2655874A1 Antibody molecules which bind human il-17 |
01/03/2008 | CA2652957A1 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
01/02/2008 | EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
01/02/2008 | EP1873244A2 Methods and compositions for inhibiting neoplastic cell growth |
01/02/2008 | EP1873239A1 Gene capable of controlling differentiation/growth of plant, and use of the same |
01/02/2008 | EP1872134A2 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
01/02/2008 | EP1871882A1 Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function |
01/02/2008 | EP1871876A2 Phytase |
01/02/2008 | EP1871810A2 Conjugated anti-psma antibodies |
01/02/2008 | EP1871809A2 Antibodies with immune effector activity and that internalize in endosialin-positive cells |
01/02/2008 | EP1871808A2 Fc VARIANTS WITH OPTIMIZED PROPERTIES |
01/02/2008 | EP1871807A2 Antibodies against cxcr4 and methods of use thereof |
01/02/2008 | EP1871806A2 ANTI-MAdCAM ANTIBODY COMPOSITIONS |
01/02/2008 | EP1871805A2 Antigen binding molecules that bind egfr, vectors encoding same, and uses thereof |
01/02/2008 | EP1871804A2 Reagents that bind ccx-ckr2 |
01/02/2008 | EP1871803A1 Stabilized anti-hepatitis b (hbv) antibody formulations |
01/02/2008 | EP1871800A1 Methods for treating and preventing fibrosis by il-21 / il-21r antagonists |
01/02/2008 | EP1871786A1 Peptide vaccine for influenza virus |
01/02/2008 | EP1871418A2 Humanized anti-cd70 binding agents and uses thereof |
01/02/2008 | EP1871417A2 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
01/02/2008 | EP1871416A2 Methods for treating osteoarthitis pain by administering a nerve growth factor antagonist and compositions containing the same |
01/02/2008 | EP1871414A1 Method for traeting inflammatory bowel disease (ibd) by an anti-cd20 antibody |
01/02/2008 | EP1871405A2 Use of rip in treating staphylococcus aureus infections |
01/02/2008 | EP1871171A2 Method of altering the binding specificity of proteins by oxidation-reduction reactions |
01/02/2008 | EP1585954A4 Mammalian sweet and amino acid heterodimeric taste receptors |
01/02/2008 | EP1578205A4 Biomarkers for intro-amniotic inflammation |
01/02/2008 | EP1502116B1 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins |
01/02/2008 | EP1499346B1 Treatment of type 1 diabetes before and after expression of predisposition markers |
01/02/2008 | EP1317476B1 Reagents for cell selection and methods of use |
01/02/2008 | EP1238056B1 SEROLOGICAL DIAGNOSTIC METHOD WITH i RICKETTSIA PULICIS /i BACTERIUM |
01/02/2008 | EP1098658A4 Engineered proteins for analyte sensing |
01/02/2008 | EP1028978B1 Methods of preparing glycosylated antibodies and antibody fragments having reactive ketone groups |
01/02/2008 | EP0942934B1 Receptor tyrosine kinase genes |
01/02/2008 | EP0610335B1 Methods for designing recombitope peptides |
01/02/2008 | CN101098958A Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
01/02/2008 | CN101098892A Antibodies against IL-13 receptor alpha 1 and uses thereof |
01/02/2008 | CN101098891A Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
01/02/2008 | CN101098890A Fc variants with altered binding to fcrn |
01/02/2008 | CN101098889A Antibody induced cell membrane wounding |
01/02/2008 | CN101096657A Preparation method of monoclonal antibody against Asial type foot-and-mouth disease virus and usage |
01/02/2008 | CN101096656A Helicobacter pylori recombinant VacA monoclonal antibody and uses thereof |
01/02/2008 | CN101096382A Aglyco products and methods of use |
01/02/2008 | CN101095952A Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies |
01/02/2008 | CN100359327C Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
01/02/2008 | CN100359005C Synthase of cereulide produced by bacillus cereus, gene encoding the same and method of detecting cereulide |
01/02/2008 | CN100358920C Methods for identifying inducers and inhibitors of propteolytic antibodies, compositions and their uses |
01/02/2008 | CN100358577C Treatment of auto immune diseases with antagonists which bind to B cell surface markers |
01/01/2008 | US7314920 Antibodies against the PRO4340 polypeptide |
01/01/2008 | US7314919 Human recombinant antibody against the hepatitis C (HCV) non structural NS3 protein nucleic acid and uses thereof |
01/01/2008 | US7314918 PRO6246 antibodies |
01/01/2008 | US7314914 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
01/01/2008 | US7314913 PRO1891 polypeptides |
01/01/2008 | US7314912 AAv scleroprotein, production and use thereof |
01/01/2008 | US7314910 In situ diagnosis, detection of antibodies, immunogenic formulations |
01/01/2008 | US7314869 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter |
01/01/2008 | US7314754 Polynucleotide encoding the hOT7T175 G protein coupled receptor |
01/01/2008 | US7314753 Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coli |
01/01/2008 | US7314747 SMRT co-repressors, transcriptional co-repressors that interact with nuclear hormone receptors |
01/01/2008 | US7314742 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
01/01/2008 | US7314734 Muteins of placental growth factor type 1, preparation method and application thereof |
01/01/2008 | US7314733 Nucleotide sequences coding tau protein for use as diagnostic tool in detection of alzheimer's and neurodegenerative disorders |
01/01/2008 | US7314722 Cytostatin II antibodies and methods |
01/01/2008 | US7314721 Autologous antibody screening; indication of regression, progression or onset |
01/01/2008 | US7314629 Inducing an immune response towards the HPV-16 Papillomavirus native E7 protein, without simultaneously inducing an immunosuppression; cancers associated with an infection |
01/01/2008 | US7314622 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
01/01/2008 | US7314619 Polypeptide for use in the treatment of cancer |
01/01/2008 | US7314618 Novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosis of |
01/01/2008 | US7314615 IκB Kinase-β (IKKβ) binding antibodies and methods of using same |
12/27/2007 | WO2007150077A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |